New drug SON-DP enters early human trials for liver and stomach cancers

NCT ID NCT06873659

Recruiting now Disease control Sponsor: Qurgen Inc. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This early-phase trial is testing a new drug called SON-DP in 96 adults with advanced solid tumors, specifically liver and gastric cancers. The main goals are to check the drug's safety, find the right dose, and see if it can control the disease. Participants receive SON-DP through an IV, and researchers will monitor side effects, tumor response, and survival.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SON-DP (a drug given through an IV)
What this could lead to: If it works, this could point toward a new treatment option for advanced liver or gastric cancers.
What could go wrong: This is a very early Phase 1 trial with only 96 people, so it is primarily checking safety and dosing. The drug may not shrink tumors or improve survival.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastric cancer gastric neoplasm liver cancer Liver Neoplasms neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTRIC CANCER LIVER CANCER SOLID TUMOR

Contacts and locations

Locations

Beijing Cancer Hospital
RECRUITING

Beijing, Beijing Municipality, 100142, China
Beijing GoBroad Hospital
RECRUITING

Beijing, Beijing Municipality, 102200, China
Cancer Hospital Chinese Academy of Medical Sciences
NOT_YET_RECRUITING

Beijing, Beijing Municipality, 100021, China
Introduction to Cancer Hospital of Shandong First Medical University (Shandong Cancer Institute,Shandong Cancer Hospital)
RECRUITING

Jinan, Shandong, 250117, China
Jiangsu Province Hospital
RECRUITING

Nanjing, Jiangsu, 210029, China
Sun Yat-sen University Cancer Center
RECRUITING

Guangzhou, Guangdong, 510060, China
Sun Yat-sen University Cancer Center
RECRUITING

Guangzhou, Guangdong, 510060, China
The First Affiliated Hospital of Xi 'an Jiaotong University
RECRUITING

Xi'an, Shaanxi, 710061, China
The First Hospital of Lanzhou University
RECRUITING

Lanzhou, Gansu, 730000, China
Zhejiang Cancer Hospital
RECRUITING

Hangzhou, Zhejiang, 310022, China
ZhongShan Hospital Fudan University
RECRUITING

Shanghai, Shanghai Municipality, 200032, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.